Consolidated Statements of Shareholders' Equity - USD ($) $ in Millions | Total | Common Stock | Additional Paid-In Capital | Retained Earnings | Treasury Stock, Common | Accumulated Other Comprehensive Loss |
Shares balance beginning of period (in shares) at Jan. 01, 2022 | | 223,000,000 | | | | |
Balance at beginning of period at Jan. 01, 2022 | $ 3,735 | $ 2 | $ 2,970 | $ 782 | | $ (19) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | |
Share-based compensation expense | 12 | | 12 | | | |
Stock Issued During Period, Shares, Employee Stock Ownership Plan | | 200,000 | | | | |
Proceeds from employee stock purchase plan | 5 | | 5 | | | |
Vested restricted stock units, net | | 700,000 | | | | |
Vested restricted stock units, net (in shares) | | (200,000) | | | | |
Exercise of stock options (in shares) | | 100,000 | | | | |
Exercise of stock options | 2 | | 2 | | | |
Tax withholding payments for net share-settled equity awards | (16) | | (16) | | | |
Series A convertible preferred stock dividends | (9) | | | (9) | | |
Net income | (7) | | | (7) | | |
Shares balance end of period (in shares) at Apr. 02, 2022 | | 223,800,000 | | | | |
Balance at end of period at Apr. 02, 2022 | 3,722 | $ 2 | 2,973 | 766 | | (19) |
Shares balance beginning of period (in shares) at Jan. 01, 2022 | | 223,000,000 | | | | |
Balance at beginning of period at Jan. 01, 2022 | 3,735 | $ 2 | 2,970 | 782 | | (19) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | |
Series A convertible preferred stock conversion to common stock | 0 | | | | | |
Unrecognized gain on interest rate caps, net of income tax | 0 | | | | | |
Net income | 63 | | | | | |
Shares balance end of period (in shares) at Jul. 02, 2022 | | 224,300,000 | | | | |
Balance at end of period at Jul. 02, 2022 | 3,804 | $ 2 | 2,994 | 827 | | (19) |
Shares balance beginning of period (in shares) at Apr. 02, 2022 | | 223,800,000 | | | | |
Balance at beginning of period at Apr. 02, 2022 | 3,722 | $ 2 | 2,973 | 766 | | (19) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | |
Share-based compensation expense | 9 | | 9 | | | |
Stock Issued During Period, Shares, Employee Stock Ownership Plan | | 200,000 | | | | |
Proceeds from employee stock purchase plan | 7 | | 7 | | | |
Exercise of stock options (in shares) | | 300,000 | | | | |
Exercise of stock options | 5 | | 5 | | | |
Series A convertible preferred stock dividends | (9) | | | (9) | | |
Unrecognized gain on interest rate caps, net of income tax | 0 | | | | | |
Net income | 70 | | | 70 | | |
Shares balance end of period (in shares) at Jul. 02, 2022 | | 224,300,000 | | | | |
Balance at end of period at Jul. 02, 2022 | $ 3,804 | $ 2 | 2,994 | 827 | | (19) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | |
Treasury stock, common (in shares) | 500,000 | | | | 400,000 | |
Shares balance beginning of period (in shares) at Dec. 31, 2022 | | 225,200,000 | | | | |
Balance at beginning of period at Dec. 31, 2022 | $ 3,961 | $ 2 | 3,036 | 1,010 | $ (14) | (73) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | |
Share-based compensation expense | 14 | | 14 | | | |
Stock Issued During Period, Shares, Employee Stock Ownership Plan | | 200,000 | | | | |
Proceeds from employee stock purchase plan | 5 | | 5 | | | |
Vested restricted stock units, net (in shares) | | 600,000 | | | | |
Exercise of stock options (in shares) | | 300,000 | | | | |
Exercise of stock options | 7 | | 7 | | | |
Tax withholding payments for net share-settled equity awards | (11) | | (11) | | | |
Series A convertible preferred stock conversion to common stock (in shares) | | 7,600,000 | | | | |
Series A convertible preferred stock dividends | (7) | | | (7) | | |
Series A convertible preferred stock conversion to common stock | 161 | | 161 | | | |
Unrecognized gain on interest rate caps, net of income tax | 1 | | | | | 1 |
Common stock repurchased (in shares) | | | | | 900,000 | |
Common stock repurchased | (34) | | | | $ (34) | |
Net income | 82 | | | 82 | | |
Shares balance end of period (in shares) at Apr. 01, 2023 | | 233,900,000 | | | | |
Balance at end of period at Apr. 01, 2023 | 4,179 | $ 2 | 3,212 | 1,085 | (48) | (72) |
Shares balance beginning of period (in shares) at Dec. 31, 2022 | | 225,200,000 | | | | |
Balance at beginning of period at Dec. 31, 2022 | 3,961 | $ 2 | 3,036 | 1,010 | (14) | (73) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | |
Series A convertible preferred stock conversion to common stock | 534 | | | | | |
Unrecognized gain on interest rate caps, net of income tax | 1 | | | | | |
Excise tax on common stock repurchases | (2) | | | | | |
Net income | 264 | | | | | |
Shares balance end of period (in shares) at Jul. 01, 2023 | | 252,300,000 | | | | |
Balance at end of period at Jul. 01, 2023 | 4,604 | $ 3 | 3,621 | 1,267 | $ (216) | (71) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | |
Treasury stock, common (in shares) | | | | | 1,300,000 | |
Shares balance beginning of period (in shares) at Apr. 01, 2023 | | 233,900,000 | | | | |
Balance at beginning of period at Apr. 01, 2023 | 4,179 | $ 2 | 3,212 | 1,085 | $ (48) | (72) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | |
Share-based compensation expense | 14 | | 14 | | | |
Stock Issued During Period, Shares, Employee Stock Ownership Plan | | 200,000 | | | | |
Proceeds from employee stock purchase plan | 8 | | 8 | | | |
Vested restricted stock units, net (in shares) | | 100,000 | | | | |
Exercise of stock options (in shares) | | 700,000 | | | | |
Exercise of stock options | 15 | | 15 | | | |
Tax withholding payments for net share-settled equity awards | 0 | | 0 | | | |
Series A convertible preferred stock conversion to common stock (in shares) | | 17,400,000 | | | | |
Series A convertible preferred stock conversion to common stock | 373 | $ 1 | 372 | | | |
Series A convertible preferred stock dividends | (1) | | | | | |
Unrecognized gain on interest rate caps, net of income tax | 0 | | | | | 1 |
Common stock repurchased (in shares) | | | | | 4,200,000 | |
Common stock repurchased | (166) | | | | $ (166) | |
Excise tax on common stock repurchases | (2) | | | | (2) | |
Net income | 182 | | | 182 | | |
Shares balance end of period (in shares) at Jul. 01, 2023 | | 252,300,000 | | | | |
Balance at end of period at Jul. 01, 2023 | $ 4,604 | $ 3 | $ 3,621 | $ 1,267 | $ (216) | $ (71) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | |
Treasury stock, common (in shares) | 1,300,000 | | | | 5,500,000 | |